SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Torben Noerup Nielsen who wrote (29980)1/8/2000 10:04:00 PM
From: celeryroot.com  Read Replies (1) | Respond to of 32384
 
funny i was just ready good old Dr. Simon's remarks >)



To: Torben Noerup Nielsen who wrote (29980)1/9/2000 12:22:00 AM
From: Skeeter Bug  Read Replies (1) | Respond to of 32384
 
torben, technically dr simon is right. in your example, perhaps everyone would have healed w/ or w/o the concoction. w/o a control group, you don't know.

practically, though, who cares over the short term. w/ misery like that, i'd stand on my head and sing the national anthem every two hours if it made me better.

i can't believe two folks on the panel voted against targretin. the lack of compassion is immense, imho. these two are mentally diseased more so than these ctcl patients are physically diseased. jmho.



To: Torben Noerup Nielsen who wrote (29980)1/9/2000 9:09:00 AM
From: Henry Niman  Respond to of 32384
 
Dr Simon does have a fixation on statistics:

RICHARD M. SIMON, D.Sc.
Chief, Biometric Research Branch
National Cancer Institute
Executive Plaza North, Room 739
Bethesda, Maryland 20892